SCHEMBL4493732

SCHEMBL4493732

Cc1c(C(C2=C(O)C(C)(c3ccccc3)OC2=O)c2ccccc2)[nH]c2ccc(F)cc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 4/20 0.40
OPRL1 P41146 3/20 0.40
MLKL Q8NB16 1/20 0.40
CSF1R P07333 1/20 0.36
KDM4E B2RXH2 4/20 0.34
ALDH1A1 P00352 2/20 0.34
GLA P06280 1/20 0.34
GAA P10253 1/20 0.34
HTT P42858 1/20 0.34
KEAP1 Q14145 1/20 0.34
NFE2L2 Q16236 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
MAP2 P11137 1/20 0.34
MAPT P10636 2/20 0.34
OGFRL1 Q5TC84 2/20 0.34
OPRD1 P41143 1/20 0.34
OPRK1 P41145 1/20 0.34
GSK3B P49841 2/20 0.33
FLT3 P36888 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4493727 1.00 OPRM1 (0.40) OPRM1OPRL1MLKLCSF1RKDM4E
SCHEMBL4491123 0.90 MLKL (0.52) OPRM1MLKLKDM4EALDH1A1HTT
SCHEMBL4491115 0.90 MLKL (0.52) OPRM1MLKLKDM4EALDH1A1HTT
SCHEMBL4501329 0.88 DAO (0.39) OPRM1OPRL1MLKLKDM4EALDH1A1
SCHEMBL4504558 0.84 MLKL (0.41) MLKLKDM4EALDH1A1HTTHPGD
SCHEMBL4504554 0.84 MLKL (0.41) MLKLKDM4EALDH1A1HTTHPGD
SCHEMBL3280713 0.84 MLKL (0.41) OPRM1OPRL1MLKLCSF1RKDM4E
SCHEMBL4507086 0.82 OPRM1 (0.40) OPRM1OPRL1MLKLCSF1RKDM4E
SCHEMBL4507089 0.82 OPRM1 (0.40) OPRM1OPRL1MLKLCSF1RKDM4E
SCHEMBL4496105 0.81 MLKL (0.42) OPRM1OPRL1MLKLCSF1RKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612099-B2 Vinylogous acid derivatives HOFFMANN-LA ROCHE INC. (US) 2009-11-03 US disclosed
EP-1957483-A1 NOVEL VINYLOGOUS ACIDS DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2008-08-20 EP disclosed
WO-2007063010-A1 NOVEL VINYLOGOUS ACIDS DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-06-07 WO disclosed
US-20070129421-A1 Vinylogous acid derivatives HOFFMANN-LA ROCHE INC. 2007-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070129421-A1 Vinylogous acid derivatives CMA1, TPSG1, TPSAB1 OPRM1 3630/4885OPRL1 3979/4885MLKL 3770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.